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Introduction
There has been an increase in the use of non-invasive
ventilation (NIV) in the intensive care setting. Guide-
lines suggest more favourable outcomes when used in
patients with chronic obstructive pulmonary disease
(COPD) and cardiogenic pulmonary oedema (CPO)[1],
yet its use often extends beyond these indications
despite no evidence of clear benefit.
Objectives
To review the practice and outcomes of NIV in our
institution over a 1 year period.
Methods
We conducted a retrospective analysis of all patients
receiving NIV for the first time at any stage of their ICU
admission between 1st January 2014 and 31st December
2014. Patients were divided into 3 groups: decompensated
respiratory failure (DRF) (pH< 7.35 + pCO2>6KPa pre-
NIV), non-decompensated respiratory failure (NDRF)
(pH>7.35 or PCO2< 6Kpa pre-NIV) or post extubation.
For each patient, the indication and duration of NIV was
recorded along with important outcomes that included
requirement and duration of mechanical ventilation (MV),
length of ICU stay and survival to ICU discharge.
Results
103 patients received NIV as a first line respiratory sup-
portive therapy for a number of indications of which
only 20% included COPD or CPO (figure 1).
38 had DRF and 63 NDRF prior to initiation of NIV.
Despite those with DRF having significantly higher
predicted acute hospital mortality than NDRF according
to admission ICNARC scoring (49% [IQR 28-62] vs. 36%
[IQR 10-54] p = 0.017), median duration of NIV received
was similar (23 [IQR 11-105] and 17 [IQR 8-73.5] hours
for DRF and NDRF respectively (p = 0.13)). There were no
significant differences between DRF and NDRF with
respect to % of patients requiring subsequent mechanical
ventilation (29% v 43%; p = 0.16), median duration of
mechanical ventilation for those subsequently intubated
(8 [IQR 4-11] vs. 9 [IQR 6-18] days; p = 0.76) or % surviv-
ing to ICU discharge (71% v 71%; p = 0.97). There was a
non-significant trend towards reduction in ICU length of
stay (LOS) for those with DRF compared with NDRF
(median ICU LOS 5.2 [IQR 3.1-8.9] v 9.8 [IQR 4.7-12.8]
days respectively; p = 0.052).
NIV following a period of mechanical ventilation was
given for 31 patients. In this cohort, NIV was administered
for a median duration of 21 hours (range 1-617 hours).
13/31 patients (42%) required re-intubation and further
periods of mechanical ventilation.
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Figure 1 Indications for NIV
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Conclusion
In our institution, the majority of patients received NIV
for indications outside those recommended by guidelines.
Those with DRF receiving NIV fared no worse compared
with NDRF in this cohort. This along with those receiving
NIV following extubation may provide a cohort of patients
who warrant further investigation.
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